Abstract
Goals of work
Five-year survival of patients with non-small cell lung cancer (NSCLC) is below 15%. Therefore, an early integration of palliative care according to the 2002 WHO definition is indispensable. In this paper, we describe methodical and financial aspects of prospective pricing of palliative care within a concept of integrated care for patients with NSCLC in Germany.
Materials and methods
Four structures of palliative care services were defined (hospital support, home care, day care and in-patient care). Prospectively, resource use was estimated, using real cost data from the finance department of the University Hospital. Resource use was forecasted on the basis of operating experience, data of the national core documentation of palliative care patients and recommendations from the European Commission.
Results
Expected average hospital support team services were priced at 483 euros and budgeted for 10% (stage 1) to 90% (stage 4) of patients. Home care (60 visits, 4,573 euros) and day-care (5 visits) services were budgeted for between 5% (stage 1) and 30% (stage 4). The resulting prospective reimbursements range from 393 euros (stage 1) to 2,503 euros (stage 4). In-patient care was excluded from the prospective payments and reimbursed separately.
Conclusions
For the first time, global reimbursements covering palliative care hospital support, home care and day care for patients with NSCLC were prospectively calculated and successfully negotiated. The contractual specification of palliative care services may contribute to transparency and quality in cancer care.
Similar content being viewed by others
References
Bruera E, Sweeney C (2002) Palliative care models: international perspective. J Palliat Med 5:319–327
Clark D, ten Have H, Janssens R (2000) Common threads? Palliative care service developments in seven European countries. Palliat Med 14:479–490
Donnelly S, Walsh D, Rybicki L (1995) The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care 11:27–32
European Commission (2003) Promoting the development and integration of palliative care mobile support teams in the hospital—The fifth framework programme 1998–2002 "Quality of Life and management of living resources
Fry WA, Phillips JL, Menck HR (1999) Ten year survey of lung lancer treatment and survival in hospitals in the United States. Cancer 86:1867–1876
Kvale PA, Simoff M, Prakash UB (2003) Palliative care. Chest 123:284S–311S
Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M (2003) Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliat Med 17:588–595
Nauck F, Radbruch L, Ostgathe C, Fuchs M, Neuwoehner KDS, Lindena G (2002) Kerndokumentation für Palliativstationen. Struktur und Ergebnisqualität. Z Palliativmed 3:41–49
Nowak D, Ochman U, Huber RM, Diederich S (2005) Screening des Lungenkarzinoms-aktueller Stand. Lung Cancer Screening—State of the Art. Pneumologie 59:178–191
Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, Smart-Curley T, Kemeny N, Norton L, Hoskins W et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183–189
Radbruch L, Nauck F, Ostgathe C, Elsner F, Bausewein C, Fuchs M, Lindena G, Neuwoehner K, Schulenberg D (2003) What are the problems in palliative care? Results from a representative survey. Support Care Cancer 1::42–451
Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 12:3–10
Vinod SK, Hui AC, Esmaili N, Hensley MJ, Barton MB (2004) Comparisons of patterns of care in lung cancer in three area health services in New South Wales, Australia. Intern Med J 34:677–683
WHO (2002) National cancer control programmes-policies and managerial guidelines. WHO, Geneva
WHO (2001) World Health Organization, Cancer incidence, mortality and survivalby site for 14 regions of the world. Discussion Paper No. 13. In:
Wiener JM, Tilly J (2003) End-of-life care in the United States: policy issues and model programs of integrated care. Int J Integr Care 3:e24
Author information
Authors and Affiliations
Corresponding author
Additional information
Christoph Ostgathe and Ronald Walshe contributed equally to the manuscript.
Rights and permissions
About this article
Cite this article
Ostgathe, C., Walshe, R., Wolf, J. et al. A cost calculation model for specialist palliative care for patients with non-small cell lung cancer in a tertiary centre. Support Care Cancer 16, 501–506 (2008). https://doi.org/10.1007/s00520-007-0337-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0337-5